Evidence map›Paper›PMID 35174404›Full record

ArticleAnnals of hematology2022

Analysis of risk factors for early death in patients with acute promyelocytic leukaemia treated with arsenic trioxide.

Yuan Wang, Wenyi Hou, Haitao Li, Xuanyu Tian, Jinqiao Li, Tianming Hu, Deli Shi, Yingmei Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yuan WangDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, People's Republic of China.
Wenyi HouDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, People's Republic of China.
Haitao LiDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, People's Republic of China.
Xuanyu TianDepartment of Oncology, The Yuechi People's Hospital, Guangan, 638373, People's Republic of China.
Jinqiao LiDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, People's Republic of China.
Tianming HuDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, People's Republic of China.
Deli ShiDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, People's Republic of China.
Yingmei ZhangDepartment of Central Laboratory, The First Affiliated Hospital of Harbin Medical University, No. 23, Youzheng Street, Nangang District, Harbin, 150001, People's Republic of China. zhangyingmei1111@126.com.ORCID http://orcid.org/0000-0001-7830-6702
Harbin Medical University · CN

Funding

Graduate practice and innovation project of Harbin Medical University YJSCX2020-82HYD
6 · The paper itself

Abstract

To date, no specific studies have evaluated early death (ED) in patients with acute promyelocytic leukaemia (APL) homogeneously treated with arsenic trioxide induction therapy and investigated according to the white blood cell (WBC) count at onset. Such patients were retrospectively analysed in this study, including 314 patients with a WBC count ≤ 10 × 10

Indexed as

ArsenicalsLeukemia, Promyelocytic, AcuteAntineoplastic Combined Chemotherapy ProtocolsArsenic TrioxideFibrinogenHumansMaleMiddle AgedOxidesRetrospective StudiesRisk FactorsTretinoinUric AcidArsenicalsArsenic TrioxideFibrinogenOxidesTretinoinUric AcidAcute promyelocytic leukaemiaArsenic trioxideEarly deathHigh-risk

Identifiers

PMID35174404
OpenAlexW4213142659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.